Trials / Recruiting
RecruitingNCT04157569
CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia
Monitoring Circulating Tumor DNA After Chemotherapy in Elderly Patients With Acute Leukemia
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Navy General Hospital, Beijing · Academic / Other
- Sex
- All
- Age
- 60 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study will monitor CtDNA After Chemotherapy in Elderly Patients With AL
Detailed description
This study will use droplet digital PCR (ddPCR) method to quantify peripheral blood plasma mutant allele frequency (MAF) in elderly acute leukemia patients after chemotherapy to evaluate the clinical value of CtDNA .
Conditions
Timeline
- Start date
- 2019-11-05
- Primary completion
- 2024-12-31
- Completion
- 2029-12-31
- First posted
- 2019-11-08
- Last updated
- 2020-02-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04157569. Inclusion in this directory is not an endorsement.